Clinical comparative study on intravenous low dose recombinant tissue plasminogen activator in the treatment of transient ischemic attack

SHEN Yongling; ZHU Haibao; LI Yong; SANG Xiaoyi; ZHANG Guanwen; QI Limin

doi:10.7619/jcmp.201719010

PDF
Cite
Share

facebook

twitter

google

linkedin

Journal of Clinical Medicine in Practice > 2017 > (19): 34-37. > DOI: 10.7619/jcmp.201719010

SHEN Yongling, ZHU Haibao, LI Yong, SANG Xiaoyi, ZHANG Guanwen, QI Limin. Clinical comparative study on intravenous low dose recombinant tissue plasminogen activator in the treatment of transient ischemic attack[J]. Journal of Clinical Medicine in Practice, 2017, (19): 34-37. DOI: 10.7619/jcmp.201719010

Citation:

PDF (280 KB)

Clinical comparative study on intravenous low dose recombinant tissue plasminogen activator in the treatment of transient ischemic attack

More Information

Graphical Abstract

Abstract

- low dose,
- recombinant tissue type plasminogen activator,
- transient ischemic attack,
- therapeutic effects

FullText(HTML)

References (0)

Cited By

Cited by

Periodical cited type(3)

1.	张晶，汪晓洲. 重组组织型纤溶酶原激活剂对缺血性脑卒中患者LDH、NO、MDA、SOD的影响. 国际检验医学杂志. 2021(03): 321-324 .
2.	吴蓓蓓，陈旭. 重组组织型纤溶酶原激活剂静脉溶栓治疗早期急性脑梗死的疗效及安全性分析. 实用临床医药杂志. 2019(05): 42-45 . 本站查看
3.	刘胡利. 纤溶酶联合阿司匹林治疗急性脑梗死的效果评价. 世界最新医学信息文摘. 2019(99): 243-244 .

Other cited types(0)

Get Citation

PDF

XML

Article views (283) PDF downloads (4) Cited by(3)

Turn off MathJax

Article Contents

Clinical comparative study on intravenous low dose recombinant tissue plasminogen activator in the treatment of transient ischemic attack

Cited by

Periodical cited type(3)

Other cited types(0)

Catalog

Export File

Citation

Format

Content